These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3730611)

  • 1. Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations.
    Rosove MH; Ismail M; Koziol BJ; Runge A; Kasper CK
    Blood; 1986 Aug; 68(2):472-8. PubMed ID: 3730611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lupus anticoagulant testing with optical end point automation.
    Luddington R; Scales C; Baglin T
    Thromb Res; 1999 Nov; 96(3):197-203. PubMed ID: 10588462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
    Alving BM; Baldwin PE; Richards RL; Jackson BJ
    Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
    Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
    Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on phospholipids in the action of a lupus coagulation inhibitor.
    Exner T; Rickard KA; Kronenberg H
    Pathology; 1975 Oct; 7(4):319-28. PubMed ID: 1223721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagent.
    Brancaccio V; Ames PR; Glynn J; Iannaccone L; Mackie IJ
    Blood Coagul Fibrinolysis; 1997 Apr; 8(3):155-60. PubMed ID: 9167015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of laboratory tests used for identification of the lupus anticoagulant.
    Lo SC; Oldmeadow MJ; Howard MA; Firkin BG
    Am J Hematol; 1989 Apr; 30(4):213-20. PubMed ID: 2494883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaolin clotting time.
    Radhakrishnan K
    Methods Mol Biol; 2013; 992():335-9. PubMed ID: 23546725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
    Clyne LP; Honig CL; Dainiak N
    Thromb Haemost; 1984 Jul; 51(3):317-20. PubMed ID: 6437003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
    Robert A
    Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for the lupus anticoagulant.
    Triplett DA
    Ric Clin Lab; 1989; 19(4):379-89. PubMed ID: 2517352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM; Barr CF; Johansen LE; Tang DB
    Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.
    Thiagarajan P; Pengo V; Shapiro SS
    Blood; 1986 Oct; 68(4):869-74. PubMed ID: 3092888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.